Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)
Clinical trial NCT03285711 · COMPLETED
Trial details
- NCT number
- NCT03285711
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-06
- Primary completion
- 2019-05-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.